Arthritis Clinical Trials in Arlington, TX

40 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.	Phase 2	Artiva Biotherapeutics, Inc.	<1 mi
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease	Phase 3	Vor Biopharma	7 mi
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden	Phase 3	Novartis Pharmaceuticals	7 mi
FX Shoulder Prospective Clinical Study	—	FX Shoulder Solutions	8 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	10 mi
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)	Phase 2	Hoffmann-La Roche	10 mi
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients	Phase 3	University of Pennsylvania	10 mi
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis	N/A	Surf Therapeutics	10 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults	Phase 1	UCB Biopharma SRL	10 mi
RA-PRO PRAGMATIC TRIAL	Phase 3	University of Alabama at Birmingham	10 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)	Phase 3	Amgen	10 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)	Phase 4	Eli Lilly and Company	10 mi
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis	Phase 3	Janssen Research & Development, LLC	11 mi
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO	Phase 1	National Cancer Institute (NCI)	12 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain	Phase 2	Eli Lilly and Company	12 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines	Phase 3	Takeda	12 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight	Phase 3	Eli Lilly and Company	12 mi
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain	Phase 2	Eli Lilly and Company	12 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis	Phase 2	AbbVie	14 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	18 mi
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants	Phase 2	Crystalys Therapeutics	18 mi
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis	Phase 1/2	Bristol-Myers Squibb	18 mi
ConsideRAte Study - Splenic Stimulation for RA	N/A	Galvani Bioelectronics	18 mi
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee	Phase 2	Pacira Pharmaceuticals, Inc	18 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	18 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee	Phase 3	Eli Lilly and Company	18 mi
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis	Phase 3	Medipost, Inc.	18 mi
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain	Phase 3	Novo Nordisk A/S	18 mi
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)	Phase 1/2	Nkarta, Inc.	18 mi
Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease	Phase 4	University of Texas Southwestern Medical Center	18 mi
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)	Phase 2	Elevara Medicines Limited	23 mi
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)	Phase 1	AbbVie	23 mi
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants	Phase 1	AstraZeneca	30 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis	Phase 2	AstraZeneca	30 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines	Phase 3	Takeda	30 mi
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis	Phase 3	Takeda	30 mi
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease	Phase 1	Cullinan Therapeutics Inc.	31 mi
MDR - PMCF Study for Taperloc Complete Stems	—	Zimmer Biomet	31 mi
Phase 1b/2 Study of IV Sarilumab in Adult With RA	Phase 1/2	Sanofi	31 mi
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis	Phase 2	Janssen Research & Development, LLC	33 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.